As alternative injection strategies have been shown to expand the array of metastatic sites in human NB xenografts [35,36], it will be of considerable interest to determine if such approaches can be used to further improve the Th-MYCN transplant model by increasing reproducibility, while maintaining the diversity of tissue involvement. This evidence concerns the gene MYCN and neuroblastoma.